BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1201741)

  • 1. Suppressive effect of cyproheptadine on L-DOPA-induced growth hormone release in man.
    Nakai Y; Imura H
    Endocrinol Jpn; 1975 Aug; 22(4):357-60. PubMed ID: 1201741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressive effect of L-dopa on human prolactin release during sleep.
    Chihara K; Kato Y; Maeda K; Ohgo S; Imura H
    Acta Endocrinol (Copenh); 1976 Jan; 81(1):19-27. PubMed ID: 174362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of parachlorophenylalanine, quipazine and cyproheptadine on growth hormone and adrenocorticotropin secretion in steers.
    Sartin JL; Kemppainen RJ; Marple DN; Carnes R; Dieberg G; Oliver EH
    Domest Anim Endocrinol; 1987 Jan; 4(1):33-41. PubMed ID: 2853663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of effect of hyperglycaemia on apomorphine induced growth hormone release in normal man.
    Nilsson KO
    Acta Endocrinol (Copenh); 1975 Oct; 80(2):230-6. PubMed ID: 1242266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the effect of cyproheptadine on growth hormone secretion.
    Lamberts SW; MacLeod RM
    Proc Soc Exp Biol Med; 1979 Oct; 162(1):116-20. PubMed ID: 504217
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of metergoline, a specific serotonin antagonist, on human growth hormone response to arginine and L-dopa.
    Pontiroli AE; Viberti GC; Tognetti A; Pozza G
    Horm Metab Res; 1976 Mar; 8(2):106-8. PubMed ID: 1261961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine effects of apomorphine: characterization of response patterns and application to schizophrenia research.
    Rotrosen J; Angrist B; Gershon S; Paquin J; Branchey L; Oleshansky M; Halpern F; Sachar EJ
    Br J Psychiatry; 1979 Nov; 135():444-56. PubMed ID: 540209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of human growth hormone secretion by cyproheptadine.
    Delitala G; Devilla L; Bionda S; Franca V
    Metabolism; 1977 Aug; 26(8):931-6. PubMed ID: 875737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression by cyproheptadine of human growth hormone and cortisol secretion during sleep.
    Chihara K; Kato Y; Maeda K; Matsukura S; Imura H
    J Clin Invest; 1976 Jun; 57(6):1393-402. PubMed ID: 180050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of L-dopa and chlorpromazine on human growth hormone and TSH secretion in normal subjects and acromegalics.
    Singh P; McDevitt DG; Mackay J; Hadden DR
    Horm Res; 1973; 4(5):293-301. PubMed ID: 4755420
    [No Abstract]   [Full Text] [Related]  

  • 11. The mechanism of action of cyproheptadine on prolactin release by cultured anterior pituitary cells.
    Lamberts SW; Verleun T; Oosterom R
    Life Sci; 1985 Jun; 36(23):2257-62. PubMed ID: 3923287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of L-dopa with and without decarboxylase inhibitor on growth hormone secretion in children with short stature.
    Fevang FO; Stoa RF; Thorsen T; Aarskog D
    Acta Paediatr Scand; 1977 Jan; 66(1):81-4. PubMed ID: 831384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of human growth hormone secretion by melatonin and cyproheptadine.
    Smythe GA; Lazarus L
    J Clin Invest; 1974 Jul; 54(1):116-21. PubMed ID: 4600047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonergic regulation of prolactin and growth hormone secretion in man.
    Lewis DA; Sherman BM
    Acta Endocrinol (Copenh); 1985 Oct; 110(2):152-7. PubMed ID: 4060968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression by thyrotropin-releasing hormone (TRH) of human growth hormone release induced by L-dopa.
    Maeda K; Kato Y; Chihara K; Ogo S; Iwasaki Y
    J Clin Endocrinol Metab; 1975 Aug; 41(2):408-11. PubMed ID: 239963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyproheptadine and desmethylcyproheptadine directly inhibit the release of adrenocorticotrophin and beta-lipotrophin/beta-endorphin activity from the neurointermediate lobe of the rat pituitary gland.
    Lamberts SW; Bons EG; Uitterlinden P; Hackeng WH
    J Endocrinol; 1983 Mar; 96(3):395-400. PubMed ID: 6300274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotoninergic control of rat growth hormone secretion.
    Smythe GA; Brandstater JF; Lazarus L
    Neuroendocrinology; 1975; 17(3):245-57. PubMed ID: 1056508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cyproheptadine on thyrotrophin and prolactin secretion in normal man.
    Golstein J; Vanhaelst L; Bruno OD; L'Hermite M
    Acta Endocrinol (Copenh); 1979 Oct; 92(2):205-13. PubMed ID: 115197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human growth hormone response to levodopa. Relation to menopause, depression, and plasma dopa concentration.
    Sachar EJ; Altman N; Gruen PH; Glassman A; Halpern FS; Sassin J
    Arch Gen Psychiatry; 1975 Apr; 32(4):502-3. PubMed ID: 1119901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory role of the serotoninergic system in hypoglycaemia-induced growth hormone release in the dog.
    Müller EE; Udeschini G; Secchi C; Zambotti F; Panerai A; Vicentini L; Cocola F; Mantegazza P
    Acta Endocrinol (Copenh); 1976 May; 82(1):71-91. PubMed ID: 131462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.